Clinical context
Visual acuity alone is insufficient when judging corneal disease or surgery. Topography and tomography, surface regularity, biomechanics, endothelial cell density, quality of vision and stability all matter. After refractive procedures, epithelial healing, dry eye, haze, ectasia and the need for enhancement should be assessed separately.
What was studied
This retrospective comparative study included 598 eyes of patients aged 18-35 years with moderate to high myopia treated with FS-LASIK, SMILE or a phakic ICL. Wavefront aberrations were measured before surgery and at six months, both on axis and at 30-degree nasal and temporal eccentric fixation.
How the evidence was produced
A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.
How to interpret the result
Central acuity and spherical equivalent do not describe the complete optical result of refractive surgery. Peripheral aberrometry identified differences among the three approaches that standard central assessment might miss. However, the smaller aberration changes observed after ICL implantation in this cohort should not be interpreted as proof of overall clinical superiority.
The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.
Clinical applicability
The study may refine technique selection and informed discussion, but its conclusions depend on baseline corneal shape, stromal thickness, equipment, nomogram and surgeon experience. Applicability requires comparison of these factors and attention to variability, uncommon complications and follow-up duration rather than mean values alone.
Limitations
The study was retrospective and non-randomized, so procedure selection and baseline differences may have influenced comparisons. Follow-up was limited to six months, and aberrations are surrogate optical measures. The abstract does not establish how the measured differences affected night vision, patient satisfaction or long-term safety.
Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.
What to verify in the source
In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.